Christopher Bergen, DPM
Podiatrist · Atlanta, GANPI 1386208874
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (43.5%), food and beverage and education — rather than concentrated in one kind of arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.5%. Reporting peaked in 2022 at $4,141 and has fallen 58.0% since, to $1,741 in 2025.
Across 100 payments — averaging $82.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Paragon 28, Inc.$1K
- Orthofix Medical, Inc.$1K
- Seapearl East, Inc$1K
- Peerless Surgical Inc.$846
- Smith+Nephew$628
- plus $1K from 17 others
What the payments were for
- Travel & lodging$3,60043%
- Food & beverage$3,48042%
- Education$1,20014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 17 | $1,611 |
| Paragon 28, Inc. | 8 | $1,437 |
| Orthofix Medical, Inc. | 16 | $1,385 |
| Seapearl East, Inc | 2 | $1,222 |
| Peerless Surgical Inc. | 9 | $846 |
| Smith+Nephew | 12 | $628 |
| Integra Lifesciences Corporation | 5 | $249 |
| Arthrex | 4 | $206 |
| Biotissue Holdings Inc. | 2 | $118 |
| Polynovo North America LLC | 3 | $105 |
| Kerecis Limited | 2 | $85 |
| Solventum Corporation | 3 | $64 |
| Paratek Pharmaceuticals, Inc. | 3 | $60 |
| Averitas Pharma Inc. | 3 | $60 |
| Reprise Biomedical, Inc. | 2 | $56 |
| AbbVie | 2 | $35 |
| Mimedx Group, Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $18 |
| Hartmann USA, Inc. | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Globus Medical | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$1,160
- MONKEY BARS$692
- PROstep$671
- Bun-Yo-Matic$516
- PROPHECY$232
- INTEGRA$157
- GRAFIX PL$153
- AUGMENT INJECTABLE$139
- Grafix XC$137
- HOFFMANN$135
- TRUELOK SYSTEM$122
- Trinity ELITE$122
- Grafix$113
How this compares
$8,280 in reported general payments places this provider in the 85th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 11 | $256 |
| Ciprofloxacin Hcl | 22 | $152 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Atlanta
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Margo JimenezAtlanta$19K
- Guang YangAtlanta$8K
- Apeksha ReddyAtlanta$7K
- Brent Blanck-SingerAtlanta$6K
- Dane UlettAtlanta$5K
- Gisele YouthAtlanta$4K
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.